The overexpression of KDM5A downregulates Pten expression by removing H3K4me3 at the Pten promoter, which consequently activates the PI3K–AKT–S6K1 signaling cascade, resulting in PD-L1 accumulation and sensitization to immune checkpoint blockade in murine cancer models [91]. This evidence concerns the gene PTEN and cancer.